Illumina-Grail Deal Blocked by EU’s Antitrust Regulator

by | Sep 6, 2022 | Business

BRUSSELS—The European Union blocked Illumina Inc.’s acquisition of Grail Inc., just days after the American life-sciences company won its case to do so in the U.S.The $7.1 billion deal would have stifled innovation and reduced choice in an emerging market for early cancer-detection blood tests, the bloc’s antitrust regulator said.

Article Attribution | Read More at Article Source

Share This